Abstract:Background SENP1 (Sentrin-specific protease 1) is involved in heart disease by regulating intracellular SUMOylation. However, the role of cell type-specific SENP1 in the setting of myocardial infarction (MI) remains to be defined. We determined whether cardiomyocyte-specific SENP1 regulates maladaptive remodeling in the ischemic heart. Methods We generated cardiomyocyte-specific SENP1 knockout and overexpression mice to assess cardiac function and ventricular remodeling responses under physiological and pathological conditions. Adult mouse cardiomyocytes and fibroblasts were separated to observe the paracrine effects of cardiomyocytes. DIA proteomic assay and bioinformatic analysis were performed to detect differential proteins in primary cardiomyocytes. Single-cell sequencing data were analyzed to identify key cardiomyocyte cluster regulated by SENP1 after MI. Mass spectrometry was performed to search for key effector proteins regulated by SENP1. Results SENP1 expression reduced in post-infarction mice and patients with heart failure. Cardiomyocyte-specific SENP1 deficiency (genetic or adeno-associated virus (AAV)-mediated) triggered a myocardial fibrotic response and progressive cardiac dysfunction. MI exacerbated the poor ventricular remodeling response mediated by SENP1 deletion, SENP1 overexpression improved cardiac function and reduced fibrosis. Further, we found that increased cardiac fibrosis in the cardiomyocyte-specific SENP1 deletion mice, associated with increased Fn expression and secretion in cardiomyocytes, promoted fibroblast activation in response to myocardial injury. Mechanistically, SENP promoted deSUMOylation of the HSP90ab1 (heat shock protein 90 alpha, class B, member 1) Lys72 and ubiquitin-dependent degradation, which reduced HSP90ab1-mediated phosphorylation of STAT3 (signal transducer and activator of transcription 3) and transcriptional activation of Fn, and then reduced fibroblast activation in the indirect coculture model. On the other hand, AAV-mediated mutation of the HSP90ab1 Lys72 ameliorated adverse ventricular remodeling and dysfunction post-MI. Conclusions SENP1 is essential for repressing STAT3-mediated Fn transcription by regulating deSUMOylation of HSP90ab1. Blockade of HSP90ab1 SUMOylation at the Lys72 site is a novel therapy effective in reversing adverse ventricular remodeling post-MI. ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest. * α-SMA : α-smooth muscle actin CTNT : cardiac troponin T ECM : extracellular matrix EF : ejection fraction FAKs : focal adhesion kinases FS : fraction shortening HSP90 : heat shock protein 90 MI : myocardial infarction MYH6 : myosin heavy chain 6 POSTN : periostin SENP : sentrin-specific protease STAT3 : signal transducer and activator of transcription 3 SUMO : small ubiquitin-like modifier [1]: pending:yes

Transcription Factor EB (TFEB) Improves Ventricular Remodeling after Myocardial Infarction by Inhibiting Wnt/β-catenin Signaling Pathway

Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis Via Paracrine Action

Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Myoblast Transplantation Improves Cardiac Function after Myocardial Infarction Through Attenuating Inflammatory Responses.

Ethyl Ferulate suppresses Post-Myocardial Infarction Myocardial Fibrosis by Inhibiting Transforming Growth Factor Receptor 1

MiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN.

Up-regulation of Paired-Related Homeobox 2 Promotes Cardiac Fibrosis in Mice Following Myocardial Infarction by Targeting of Wnt5a.

Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis

Soluble transforming growth factor-β1 receptor II might inhibit transforming growth factor-β-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats:

MicroRNA-19a-3p augments TGF-β1-induced cardiac fibroblast activation via targeting BAMBI

Abstract 516: Endothelial Foxp1 Regulates Cardiac Remodeling Via Tgfbeta and Et-1 Signal Pathway

Protective Effect of CD137 Deficiency against Post-infarction Cardiac Fibrosis and Adverse Cardiac Remodeling via ERK1/2 Signaling Pathways

Lactoferrin Attenuates Cardiac Fibrosis and Cardiac Remodeling after Myocardial Infarction Via Inhibiting Mtorc1/s6k Signaling Pathway

KIAA1199/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice

Loss of Fibulin-2 Protects Against Progressive Ventricular Dysfunction after Myocardial Infarction.

Transforming Growth Factor Β and Its Role in Heart Disease.

Exogenous High‐mobility Group Box 1 Protein Prevents Postinfarction Adverse Myocardial Remodeling Through TGF‐β/Smad Signaling Pathway

MiR-1908 Improves Cardiac Fibrosis after Myocardial Infarction by Targeting TGF-β1.

Notch Signaling Inhibits Cardiac Fibroblast To Myofibroblast Transformation By Antagonizing Tgf-Beta 1/Smad3 Signaling